Gilead poaches new pharma development and manufacturing chief from cell therapy 2.0 player

Gilead has raided one of the up-and-coming cell therapy 2.0 biotechs to find its new head of pharma development and manufacturing.

Steve Harr

Dan O’Day’s pharma player has recruited Stacey Ma from Sana Biotechnology for the senior executive team. A Genentech vet, Ma has been...

Click to view original post